Helicobacter Infection and Gastric Adenoma

• Published in: Microorganisms (Basel) Vol. 9; no. 1; p. 108
• Main Authors: Bertz, Simone, Angeloni, Miriam, Drgac, Jan, Falkeis, Christina, Lang-Schwarz, Corinna, Sterlacci, William, Veits, Lothar, Hartmann, Arndt, Vieth, Michael
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 05-01-2021; MDPI
• Subjects: Adenoma; Atrophy; Classification; Cysts; Diagnostic systems; Endoscopy; familial adenomatosis coli; foveolar-type adenoma; gastric adenoma; Gastric cancer; Gastritis; Helicobacter; Infections; intestinal tubular adenoma; Intestine; Localization; Metaplasia; Mucosa; Mutation; oxyntic gland adenoma; Pathology; Polyps; pyloric gland adenoma; Tumors; intestinal tubular adenoma; oxyntic gland adenoma; autoimmune; Helicobacter; pyloric gland adenoma; familial adenomatosis coli; gastric adenoma; gastritis; foveolar-type adenoma
• ISSN: 2076-2607; 2076-2607
• DOI: 10.3390/microorganisms9010108

We aimed to provide insight into the actual frequencies of gastric adenoma types and their association with gastritis status and associated mucosal changes with a focus on Helicobacter infection and the operative link on gastritis assessment (OLGA)/operative link on gastric intestinal metaplasia assessment (OLGIM) staging.
From the archive of the Institute of Pathology in Bayreuth, we collected a consecutive series of 1058 gastric adenomas diagnosed between 1987 and 2017. Clinicopathological parameters retrieved from diagnostic reports included adenoma type and localization, associated mucosal changes in antrum and corpus (i.e., type of gastritis, the extent of intestinal metaplasia and atrophy), gender, date of birth, and date of diagnosis.
Intestinal-type adenoma was the most frequent adenoma (89.1%), followed by foveolar-type adenoma (4.3%), pyloric gland adenoma (3.4%), adenomas associated with hereditary tumor syndromes (2.8%), and oxyntic gland adenoma (0.4%). Adenomas were found in the background of
(
) gastritis in 23.9%, Ex-
gastritis in 36.0%, autoimmune gastritis in 24.8%, chemical reactive gastritis in 7.4%, and others in 0.1%. More than 70% of patients with gastric adenomas had low-risk stages in OLGA and OLGIM.
We found a higher frequency of foveolar-type adenoma than anticipated from the literature. It needs to be questioned whether OLGA/OLGIM staging can be applied to all patients.